Cargando…

Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study

OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Naveen, Delu, Vikram, Shukla, Alok, Singh, Rishi Kant, Ulasov, Ilya, Fayzullina, Daria, Kuma, Sandeep, Patel, Anand Kumar, Yadav, Lokesh, Tiwari, Ruchi, Rachana, Kumari, Mohanta, Shivashish Priyadarshi, Kumar, Sanjay, Kaushalendra, Kaushalendra, Acharya, Arbind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505880/
https://www.ncbi.nlm.nih.gov/pubmed/37378948
http://dx.doi.org/10.31557/APJCP.2023.24.6.2157
_version_ 1785106999791321088
author Kumar, Naveen
Delu, Vikram
Shukla, Alok
Singh, Rishi Kant
Ulasov, Ilya
Fayzullina, Daria
Kuma, Sandeep
Patel, Anand Kumar
Yadav, Lokesh
Tiwari, Ruchi
Rachana, Kumari
Mohanta, Shivashish Priyadarshi
Kumar, Sanjay
Kaushalendra, Kaushalendra
Acharya, Arbind
author_facet Kumar, Naveen
Delu, Vikram
Shukla, Alok
Singh, Rishi Kant
Ulasov, Ilya
Fayzullina, Daria
Kuma, Sandeep
Patel, Anand Kumar
Yadav, Lokesh
Tiwari, Ruchi
Rachana, Kumari
Mohanta, Shivashish Priyadarshi
Kumar, Sanjay
Kaushalendra, Kaushalendra
Acharya, Arbind
author_sort Kumar, Naveen
collection PubMed
description OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, its acute toxicity study being lacking. MATERIALS AND METHODS: OECD-423 guidelines were followed during this study and the parameters were divided into four categories - behavioral parameters, physiological parameters, histopathological parameters, and supplementary tests. The behavioral parameters included feeding, body weight, belly size, organ weight and size, and mice behavior. The physiological parameters consisted of blood, liver, and kidney indicators. In histopathological parameters hematoxylin and eosin staining was performed to analyse the histological changes in the mice organs after FNC exposure. In addition, supplementary tests were conducted to assess cellular viability, DNA fragmentation and cytokine levels (IL-6 and TNF-α) in response to FNC. RESULTS: In the behavioral parameters FNC induced changes in the mice-to-mice interaction and activities. Mice’s body weight, belly size, organ weight, and size remained unchanged. Physiological parameters of blood showed that FNC increased the level of WBC, RBC, Hb, and neutrophils and decreased the % count of lymphocytes. Liver enzymes SGOT (AST), and ALP was increased. In the renal function test (RFT) cholesterol level was significantly decreased. Histopathological analysis of the liver, kidney, brain, heart, lungs, and spleen showed no sign of tissue damage at the highest FNC dose of 25 mg/kg b.wt. Supplementary tests for cell viability showed no change in viability footprint, through our recently developed dilution cum-trypan (DCT) assay, and Annexin/PI. No DNA damage or apoptosis was observed in DAPI or AO/EtBr studies. Pro-inflammatory cytokines IL-6 and TNF-α increased in a dose-dependent manner. CONCLUSION: This study concluded that FNC is safe to use though higher concentration shows slight toxicity.
format Online
Article
Text
id pubmed-10505880
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-105058802023-09-19 Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study Kumar, Naveen Delu, Vikram Shukla, Alok Singh, Rishi Kant Ulasov, Ilya Fayzullina, Daria Kuma, Sandeep Patel, Anand Kumar Yadav, Lokesh Tiwari, Ruchi Rachana, Kumari Mohanta, Shivashish Priyadarshi Kumar, Sanjay Kaushalendra, Kaushalendra Acharya, Arbind Asian Pac J Cancer Prev Research Article OBJECTIVES: The present study aimed to provide an insight into the acute toxicity of a novel fluorinated nucleoside analogue (FNA), FNC (Azvudine or2’-deoxy-2’-β-fluoro-4’-azidocytidine). FNC showed potent anti-viral and anti-cancer activities and approved drug for high-load HIV patients, despite, its acute toxicity study being lacking. MATERIALS AND METHODS: OECD-423 guidelines were followed during this study and the parameters were divided into four categories - behavioral parameters, physiological parameters, histopathological parameters, and supplementary tests. The behavioral parameters included feeding, body weight, belly size, organ weight and size, and mice behavior. The physiological parameters consisted of blood, liver, and kidney indicators. In histopathological parameters hematoxylin and eosin staining was performed to analyse the histological changes in the mice organs after FNC exposure. In addition, supplementary tests were conducted to assess cellular viability, DNA fragmentation and cytokine levels (IL-6 and TNF-α) in response to FNC. RESULTS: In the behavioral parameters FNC induced changes in the mice-to-mice interaction and activities. Mice’s body weight, belly size, organ weight, and size remained unchanged. Physiological parameters of blood showed that FNC increased the level of WBC, RBC, Hb, and neutrophils and decreased the % count of lymphocytes. Liver enzymes SGOT (AST), and ALP was increased. In the renal function test (RFT) cholesterol level was significantly decreased. Histopathological analysis of the liver, kidney, brain, heart, lungs, and spleen showed no sign of tissue damage at the highest FNC dose of 25 mg/kg b.wt. Supplementary tests for cell viability showed no change in viability footprint, through our recently developed dilution cum-trypan (DCT) assay, and Annexin/PI. No DNA damage or apoptosis was observed in DAPI or AO/EtBr studies. Pro-inflammatory cytokines IL-6 and TNF-α increased in a dose-dependent manner. CONCLUSION: This study concluded that FNC is safe to use though higher concentration shows slight toxicity. West Asia Organization for Cancer Prevention 2023 /pmc/articles/PMC10505880/ /pubmed/37378948 http://dx.doi.org/10.31557/APJCP.2023.24.6.2157 Text en https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-Non Commercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Research Article
Kumar, Naveen
Delu, Vikram
Shukla, Alok
Singh, Rishi Kant
Ulasov, Ilya
Fayzullina, Daria
Kuma, Sandeep
Patel, Anand Kumar
Yadav, Lokesh
Tiwari, Ruchi
Rachana, Kumari
Mohanta, Shivashish Priyadarshi
Kumar, Sanjay
Kaushalendra, Kaushalendra
Acharya, Arbind
Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title_full Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title_fullStr Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title_full_unstemmed Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title_short Safety Assessment of a Nucleoside Analogue FNC (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in Balb/c Mice: Acute Toxicity Study
title_sort safety assessment of a nucleoside analogue fnc (2’-deoxy-2’-β-fluoro-4’-azidocytidine ) in balb/c mice: acute toxicity study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505880/
https://www.ncbi.nlm.nih.gov/pubmed/37378948
http://dx.doi.org/10.31557/APJCP.2023.24.6.2157
work_keys_str_mv AT kumarnaveen safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT deluvikram safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT shuklaalok safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT singhrishikant safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT ulasovilya safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT fayzullinadaria safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT kumasandeep safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT patelanandkumar safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT yadavlokesh safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT tiwariruchi safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT rachanakumari safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT mohantashivashishpriyadarshi safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT kumarsanjay safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT kaushalendrakaushalendra safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy
AT acharyaarbind safetyassessmentofanucleosideanaloguefnc2deoxy2bfluoro4azidocytidineinbalbcmiceacutetoxicitystudy